Biotech · Private company
Marengo Therapeutics, Inc.
Track this companyFree. Adds Marengo Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Docetaxel (Taxotere)Phase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Irinotecan (Camptosar)Phase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Sacituzumab Govitecan (SG)Phase 2 · Triple Negative Locally Advanced Non-resectable Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- STAR0602Phase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- STAR0602Phase 2 · Triple Negative Locally Advanced Non-resectable Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Mar 24, 2025ClinicalTrials.gov NCT06827613 · fetched Nov 12, 2026
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Jan 4, 2023ClinicalTrials.gov NCT05592626 · fetched Nov 12, 2026